Shinhan Investment
VC Fund
Seoul, South Korea
Shinhan Investment is a VC fund in Seoul focused on Health Care and Software. Shinhan Investment Corp. is a financial services company based out of 여의대로 70, 영등포구, 서울특별시, South Korea.
- Total investments:
- 37
- Last investment:
- Lead investor:
- 24%
Last updated:
For AI agents: llms.txt
Industries Shinhan Investment invests in
Stages Shinhan Investment invests in
Countries Shinhan Investment invests in
Round sizes
Round size
- Series A
- $1.4M–$23M
- Series B
- $12k–$52M
- Series C
- $26M–$106M
Investment Focus
Industry
- Health Care 7 (19%)
- Software 6 (16%)
- Biotechnology 6 (16%)
- Manufacturing 6 (16%)
- Medical 5 (14%)
Stage
- Series A 14 (38%)
- Series B 10 (27%)
- Series C 5 (14%)
- Seed 3 (8%)
- Corporate Round 2 (5%)
Country
- South Korea 26 (70%)
- United States 6 (16%)
- Bermuda 1 (3%)
- Singapore 1 (3%)
- United Kingdom 1 (3%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Inocras
|
Inocras Inc. specializes in whole genome sequencing and analytics, focusing on providing insights for personalized care in cancer and rare diseases. Utilizing artificial intelligence, Inocras aims to revolutionize healthcare by enabling precision medicine. The company offers services to patients, healthcare providers, researchers, and partners,seeking to unlock new possibilities in precision health. With a commitment to innovation, Inocras has introduced products like CancerVision and RareVision, designed to enhance diagnosis and treatment strategies through comprehensive genomic analysis. | $20K / Series B / Jul 01, 2026 | |
24X Bermuda
|
24X Bermuda operates an electronic brokerage platform that facilitates foreign exchange (FX) spot transactions for institutional users. The company addresses market challenges such as fragmented pools of liquidity and high access fees. It also holds a 'Class T' Cryptocurrency DABA License, allowing it to offer cryptocurrency tradingservices. The platform is designed to introduce both US and non-US institutional clients to efficient and cost-effective trading solutions. | Corporate Round / Oct 30, 2025 | |
IMBiologics
|
IMBiologics is a biotechnology company that develops antibody-based drug candidates for diseases such as cancer and immune-related conditions. It conducts research and development using its own platforms to discover new therapeutic molecules. | $29.5M / Series C / Oct 14, 2025 | |
Vroong
|
Mesh Korea is an IT-based logistics startup, which established Korea's first last-mile logistics network and became the primary provider of integrated logistics services with in-house logistics solutions.VROONG, Mesh Korea's logistics brand, creates new value not only by providing delivery services, but also by connecting information.Currently, VROONG provides four services; premium delivery services, 'VROONG Prime', integrated logistics management solution, 'VROONG TMS', premium fresh food delivery services, 'VROONG Fresh', and premium delivery magazine, 'VROONG Collection.'With more than 80 VROONG Stations and 13,000 riders across the nation, VROONG provides faster and more accurate delivery services. | $7.2M / Venture - Series Unknown / Sep 02, 2025 | |
Canteen9
|
Canteen9 is the producer of supplement products intended to provide a well-balanced diet of essential nutrients for children without excessive intake. The company's product offering includes supplements for eyes, bones, skin, and overall immunity, enabling parents to take care of their children by enhancing their well-being. | $2.2M / Series A / Apr 29, 2025 | |
|
Vroong
|
Mesh Korea is an IT-based logistics startup, which established Korea's first last-mile logistics network and became the primary provider of integrated logistics services with in-house logistics solutions.VROONG, Mesh Korea's logistics brand, creates new value not only by providing delivery services, but also by connecting information.Currently, VROONG provides four services; premium delivery services, 'VROONG Prime', integrated logistics management solution, 'VROONG TMS', premium fresh food delivery services, 'VROONG Fresh', and premium delivery magazine, 'VROONG Collection.'With more than 80 VROONG Stations and 13,000 riders across the nation, VROONG provides faster and more accurate delivery services. | $20.8M / Venture - Series Unknown / Mar 17, 2025 | |
FIRMMIT
|
FIRMMIT is an ag-tech company that optimizes growth data by securing and analyzing agricultural technology data. | $7.4M / Series B / Oct 04, 2024 | |
Bright Machines
|
Bright Machines is a manufacturing startup that aims to eliminate manual labor from manufacturing electronic devices by combining robots and new software. Its software-defined manufacturing platform helps customers innovate faster to meet the growing demands of a new era of manufacturing.The company was founded by former Autodesk executive, ArmarHanspal, in 2018. | $106M / Series C / Jun 25, 2024 | |
|
B:eat Corp
|
B: eat is a retail automation platform intended to run a robot-based cafe. | Series B / Nov 28, 2023 | |
YMX
|
YMX is a firm that specializes in XR-based industrial metabus platforms, with solutions that address chronic pain points throughout the manufacturing industry's life cycle, from facility building to production and maintenance. | $4M / Series A / Aug 29, 2023 | |
| See all 37 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Shinhan Investment invest in?
Shinhan Investment invests primarily in Health Care, Software and Biotechnology startups, most often at Series A and Series B stage. Most of the 37 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Shinhan Investment's check size?
Shinhan Investment typically joins rounds of $1.4M–$23M at Series A, $12k–$52M at Series B and $26M–$106M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Shinhan Investment participates in.
When did Shinhan Investment last invest?
The most recent investment recorded for Shinhan Investment closed in Jul 2026. Shizune tracks 37 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
